Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Title of Study:
A randomized, parallel, double-blind, multi-center, comparative study to evaluate the
efficacy and safety of Cosalin monotherapy versus Cosalin and Xarlin combination therapy in
patients with allergic rhinitis
Objective of study:
To exploratively evaluate superiority of combination therapy - twice-daily Cosalin Tab
(Petasites hybridus CO2 extract) with once-daily Xarlin Tab (Levocetirizine HCl) - compared
to monotherapy of Cosalin with allergic rhinitis subjects.